Yoon, Sang-Oh <br/><br/>
Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression.  [electronic resource] 

 -  Molecular cancer therapeutics  Nov 2006 
 - 2666-75 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-06-0321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biflavonoids--pharmacology<br/>Breast Neoplasms--metabolism<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fibrosarcoma--metabolism<br/>Flavonoids--pharmacology<br/>Humans<br/>Matrix Metalloproteinase 9--metabolism<br/>Matrix Metalloproteinase Inhibitors<br/>Neoplasm Invasiveness<br/>Neoplasms--enzymology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Tumor Cells, Cultured<br/>NF-kappaB-Inducing Kinase